Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Maccura Biotechnology Co.Ltd
  6. News
  7. Summary
    300463   CNE1000020H3

MACCURA BIOTECHNOLOGY CO.LTD

(300463)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-09-29
16.75 CNY   +0.84%
07/15Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
06/20Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO
MT
06/10Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

DMaccura Biotechnology Co.Ltd Approves Cash Dividend for 2021, Payable on May 19, 2022

05/13/2022 | 03:39pm EDT

Maccura Biotechnology Co.Ltd approved cash dividend/10 shares (tax included) of CNY 4.70956500 of A shares for the year 2021. Record date is May 18, 2022. Ex-date is May 19, 2022.

Payment date is May 19, 2022.


© S&P Capital IQ 2022
All news about MACCURA BIOTECHNOLOGY CO.LTD
07/15Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, ..
CI
06/20Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO
MT
06/10Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO
MT
05/13DMaccura Biotechnology Co.Ltd Approves Cash Dividend for 2021, Payable on May 19, 2022
CI
05/11Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2021
CI
04/27Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March..
CI
04/20Maccura Biotechnology Co.Ltd Proposes Final Dividend for the Year 2021
CI
04/19Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December ..
CI
02/17Maccura Biotechnology Nets $246 Million From Private Placement
MT
01/25Maccura Biotechnology Co.Ltd announced that it has received CNY 1.57416 billion in fund..
CI
More news
Financials
Sales 2022 4 190 M 589 M 589 M
Net income 2022 1 090 M 153 M 153 M
Net Debt 2022 - - -
P/E ratio 2022 9,41x
Yield 2022 -
Capitalization 10 259 M 1 442 M 1 442 M
Capi. / Sales 2022 2,45x
Capi. / Sales 2023 2,30x
Nbr of Employees 2 865
Free-Float 59,6%
Chart MACCURA BIOTECHNOLOGY CO.LTD
Duration : Period :
Maccura Biotechnology Co.Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MACCURA BIOTECHNOLOGY CO.LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 16,75 CNY
Average target price 27,83 CNY
Spread / Average Target 66,1%
EPS Revisions
Managers and Directors
Ming Jian Wu General Manager & Director
Shan Yin Chief Financial Officer
Yong Tang Chairman
Yuan Zou Chairman-Supervisory Board
Kai Cheng Liang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MACCURA BIOTECHNOLOGY CO.LTD-42.62%1 442
BIOMÉRIEUX-32.81%9 763
DIASORIN S.P.A.-29.62%6 182
LANTHEUS HOLDINGS, INC.158.57%5 135
NATERA, INC.-49.64%4 560
AUTOBIO DIAGNOSTICS CO., LTD.0.09%4 542